Oorsprong van het eerstegraads netwerk van Bhawanjit K. Brar
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Zensun USA, Inc.
 Zensun USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Zensun (Shanghai) Sci & Tech Co., Ltd., Zensun USA, Inc. is a company that manufactures bio-therapeutic products. The company is based in San Diego, CA. The company was founded by Xi Fu Liu.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Bhawanjit K. Brar via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Zensun (Shanghai) Sci & Tech Co., Ltd.
 Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Chief Executive Officer Founder General Counsel General Counsel | |
| Fudan University | College/University | Undergraduate Degree Masters Business Admin | |
| University of Illinois | College/University | Graduate Degree Undergraduate Degree | |
The Victor Chang Cardiac Research Institute
 The Victor Chang Cardiac Research Institute Miscellaneous Commercial ServicesCommercial Services The Victor Chang Cardiac Research Institute is a research center dedicated to finding cures for heart disease through world-class and cutting-edge medical research. The institute is located in Western Australia and is the first dedicated center of heart research in the region. The scientists at the institute are urgently working to discover better ways of understanding, diagnosing, treating, and preventing the onset of heart disease. The CEO of the Australian company is Mark Rodrick Granger Johnson. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The State University of New York | College/University | Doctorate Degree | |
| Hebei University of Science & Technology | College/University | Undergraduate Degree | |
| Chinese Academy of Sciences | College/University | Doctorate Degree | |
| Soochow University | College/University | Doctorate Degree |
Statistieken
Internationaal
| China | 6 |
| Verenigde Staten | 3 |
| Australië | 2 |
Sectoraal
| Consumer Services | 7 |
| Health Technology | 2 |
| Commercial Services | 2 |
Operationeel
| Chairman | 4 |
| Corporate Officer/Principal | 4 |
| Founder | 3 |
| Undergraduate Degree | 3 |
| Doctorate Degree | 3 |
Sterkste connecties
| Insiders | |
|---|---|
| Ming Dong Zhou | 5 |
| Xi Fu Liu | 4 |
| Xin Yan Li | 3 |
| Ming Lin Li | 3 |
| Kate Vilaychack-Rizzo | 3 |
- Beurs
- Insiders
- Bhawanjit K. Brar
- Bedrijfsconnecties
